| S1773 |
Oxytetracycline (Terramycin)
|
Oxytetracycline (Terramycin) is a broad-spectrum tetracycline antibiotic used to treat infections with bacteria.
|
-
Sci Rep, 2018, 8(1):7653
-
Front Microbiol, 2016, 7: 1765
|
|
| E4932 |
Amikacin
|
Amikacin(BAY 41-6551, Lukadin) is a semisynthetic aminoglycoside, derived from kanamycin-A, that acts as an inhibitor of the Z ring formation, leading to the inhibition of cell division. It is used to treat serious infections caused by aerobic Gram-negative bacteria, mycobacteria, Nocardia, and life-threatening infections in neonates.
|
|
|
| S7417 |
Puromycin Dihydrochloride
|
Puromycin 2HCl is an aminonucleoside antibiotic derived from Streptomyces alboniger. It is an inhibitor of protein synthesis and has been used to study transcription regulatory mechanisms that control the sequential and coordinated expression of genes during cell differentiation.
|
-
Signal Transduct Target Ther, 2025, 10(1):182
-
Cell Stem Cell, 2025, S1934-5909(25)00181-X
-
Nat Commun, 2025, 16(1):4792
|
|
| S4163 |
Doxycycline Hyclate
|
Doxycycline Hyclate is a member of the tetracycline antibiotics group, and is commonly used to treat a variety of infections. It is also an inhibitor of matrix metallo-proteinases (MMP).
|
-
Cell Discov, 2025, 11(1):41
-
Adv Sci (Weinh), 2025, 12(41):e03977
-
Dev Cell, 2025, S1534-5807(25)00405-8
|
|
| S5159 |
Doxycycline
|
Doxycycline (Vibramycin, Doxytetracycline, Doxiciclina, Doxycyclinum) is an antibiotic that is used in the treatment of a number of types of infections caused by bacteria and protozoa. Doxycycline is also a nonspecific matrix metalloproteinase (MMP) inhibitor.
|
-
Nature, 2025, 10.1038/s41586-025-09222-5
-
Cell Stem Cell, 2025, S1934-5909(25)00181-X
-
Nat Commun, 2025, 16(1):7898
|
|
| S1403 |
Tigecycline
|
Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation. This compound induces autophagy by downregulating the PI3K-AKT-mTOR pathway.
|
-
J Infect Dis, 2025, 232(3):e416-e420
-
NPJ Antimicrob Resist, 2025, 3(1):12
-
Int J Mol Sci, 2024, 25(9)4887
|
|
| S2572 |
Streptomycin sulfate
|
Streptomycin sulfate(Phytomycin) is a sulfate salt of streptomycin that is a protein synthesis inhibitor.
|
-
Front. Oncol, 2023-, Volume 13
-
Front Oncol, 2023, 13:1118268
-
Transl Oncol, 2022, 26:101502
|
|
| S2908 |
Hygromycin B
|
Hygromycin B (Hygrovetine), a selective antibiotic that is effective on most bacteria, fungi and higher eukaryotes, inhibits protein synthesis by interfering with translocation and causing mistranslation at the 70S ribosome.
|
-
Nat Commun, 2024, 15(1):10594
-
Redox Biol, 2024, 76:103349
-
Front Pharmacol, 2024, 15:1432851
|
|
| S4147 |
Azithromycin Dihydrate
|
Azithromycin Dihydrate(CP-62993 dihydrate) is an acid stable orally administered macrolide antimicrobial drug, structurally related to erythromycin.
|
-
J Cell Biochem, 2022, 10.1002/jcb.30213
-
Adv Ther (Weinh), 2020, 2000034
-
PLoS Comput Biol, 2020, 16(12):e1008489
|
|
| S2555 |
Clarithromycin
|
Clarithromycin (A-56268) is a macrolide antibiotic and a CYP3A4 inhibitor, used to treat a number of bacterial infections.
|
-
Circulation, 2024, 150(7):563-576
-
Microorganisms, 2022, 10(7)1421
-
Cell Biol Toxicol, 2021, 10.1007/s10565-021-09646-5
|
|
| S1635 |
Erythromycin
|
Erythromycin (E-Mycin) is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin (IC50=1.5 μg/ml).
|
-
Autophagy, 2025, 1-17.
-
Infect Drug Resist, 2023, 16:4867-4879
-
Infect Drug Resist, 2023, 16:4867-4879
|
|
| S2574 |
Tetracycline HCl
|
Tetracycline HCl (NCI-c55561) is a hydrochloride salt of tetracycline that is a broad-spectrum polyketide antibiotic.
|
-
Nat Commun, 2024, 15(1):2377
-
Antiviral Res, 2020, 185:104993
-
PLoS Pathog, 2020, 16;16(3):e1008341
|
|
| S4056 |
Retapamulin
|
Retapamulin (SB-275833) is a topical antibiotic, which binds to both E. coli and S. aureus ribosomes with similar potencies with Kd of 3 nM.
|
-
Infect Drug Resist, 2023, 16:4867-4879
-
Infect Drug Resist, 2023, 16:4867-4879
-
Pediatr Infect Dis J, 2021, 40(7):637-638
|
|
| S1677 |
Chloramphenicol
|
Chloramphenicol (Chloromycetin) is a bacteriostatic by inhibiting protein synthesis.
|
-
Cell Rep, 2021, 34(3):108631
-
EMBO Rep, 2021, e53081
-
Oncotarget, 2018, 9(40):26086-26095
|
|
| S4279 |
Demeclocycline HCl
|
Demeclocycline HCl(Demeclocycline hydrochloride) is a tetracycline antibiotic via inhibition of protein synthesis by bacteria, used for the treatment of bacterial infections.
|
-
Cancer Res Commun, 2025, 10.1158/2767-9764.CRC-24-0433
-
J Biol Chem, 2020, 10.1074/jbc.RA119.011633.
-
Sci Rep, 2018, 8(1):7653
|
|
| S2510 |
Spectinomycin 2HCl
|
Spectinomycin 2HCl (Actinospectacin) is a new parenteral antibiotic prepared from Streptomyces spectabilis.
|
-
Cell Rep, 2020, 32(2):107897
|
|
| S2514 |
Tobramycin
|
Tobramycin (NSC 180514,Deoxykanamycin B, Nebramycin Factor 6) is an aminoglycoside antibiotic with an IC50 of 9.7 μM.
|
-
Oncotarget, 2018, 9(40):26086-26095
|
|
| S4490 |
Tetracycline
|
Tetracycline (TC) is a broad-spectrum antibiotic that exhibits activity against a wide range of microorganisms including gram-positive and gram-negative bacteria, chlamydiae, mycoplasmas, rickettsiae, and protozoan parasites.
|
-
Redox Biol, 2025, 84:103649
-
bioRxiv, 2025, 2025.01.08.632009
-
PeerJ, 2022, 10:e13719
|
|
| S3496 |
Lefamulin acetate (Xenleta)
|
Lefamulin acetate (Xenleta, BC-3781 acetate) is a pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP) treatment. It inhibits protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome, thus preventing the binding of transfer RNA for peptide transfer.
|
-
J Biol Chem, 2022, 298(5):101909
|
|
| S2315 |
Kanamycin sulfate
|
Kanamycin sulfate (Kanamycin monosulfate, Ophtalmokalixan) is an aminoglycoside antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections.
|
-
Heliyon, 2024, 10(11):e32571
-
Oncotarget, 2018, 9(40):26086-26095
|
|
| S5417 |
Spectinomycin dihydrochloride pentahydrate
|
Spectinomycin dihydrochloride pentahydrate (Trobicin) is a widely used antibiotic that inhibits bacterial protein synthesis by blocking translocation of messenger RNA and transfer RNAs on the ribosome.
|
|
|
| E4867 |
Omadacycline
|
Omadacycline(Amadacycline) is an oral aminomethylcycline antibacterial antibiotic used to treat moderate-to-severe infections, such as community-acquired pneumonia and acute bacterial skin and skin structure infections caused by susceptible organisms. It inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. This compound has broad-spectrum antibacterial activity and is effective against Gram-positive and Gram-negative aerobic, anaerobic, and atypical bacteria.
|
|
|
| S1773 |
Oxytetracycline (Terramycin)
|
Oxytetracycline (Terramycin) is a broad-spectrum tetracycline antibiotic used to treat infections with bacteria. |
- Sci Rep, 2018, 8(1):7653
- Front Microbiol, 2016, 7: 1765
|
|
| S7417 |
Puromycin Dihydrochloride
|
Puromycin 2HCl is an aminonucleoside antibiotic derived from Streptomyces alboniger. It is an inhibitor of protein synthesis and has been used to study transcription regulatory mechanisms that control the sequential and coordinated expression of genes during cell differentiation. |
- Signal Transduct Target Ther, 2025, 10(1):182
- Cell Stem Cell, 2025, S1934-5909(25)00181-X
- Nat Commun, 2025, 16(1):4792
|
|
| S4163 |
Doxycycline Hyclate
|
Doxycycline Hyclate is a member of the tetracycline antibiotics group, and is commonly used to treat a variety of infections. It is also an inhibitor of matrix metallo-proteinases (MMP). |
- Cell Discov, 2025, 11(1):41
- Adv Sci (Weinh), 2025, 12(41):e03977
- Dev Cell, 2025, S1534-5807(25)00405-8
|
|
| S5159 |
Doxycycline
|
Doxycycline (Vibramycin, Doxytetracycline, Doxiciclina, Doxycyclinum) is an antibiotic that is used in the treatment of a number of types of infections caused by bacteria and protozoa. Doxycycline is also a nonspecific matrix metalloproteinase (MMP) inhibitor. |
- Nature, 2025, 10.1038/s41586-025-09222-5
- Cell Stem Cell, 2025, S1934-5909(25)00181-X
- Nat Commun, 2025, 16(1):7898
|
|
| S1403 |
Tigecycline
|
Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation. This compound induces autophagy by downregulating the PI3K-AKT-mTOR pathway. |
- J Infect Dis, 2025, 232(3):e416-e420
- NPJ Antimicrob Resist, 2025, 3(1):12
- Int J Mol Sci, 2024, 25(9)4887
|
|
| S2572 |
Streptomycin sulfate
|
Streptomycin sulfate(Phytomycin) is a sulfate salt of streptomycin that is a protein synthesis inhibitor. |
- Front. Oncol, 2023-, Volume 13
- Front Oncol, 2023, 13:1118268
- Transl Oncol, 2022, 26:101502
|
|
| S2908 |
Hygromycin B
|
Hygromycin B (Hygrovetine), a selective antibiotic that is effective on most bacteria, fungi and higher eukaryotes, inhibits protein synthesis by interfering with translocation and causing mistranslation at the 70S ribosome. |
- Nat Commun, 2024, 15(1):10594
- Redox Biol, 2024, 76:103349
- Front Pharmacol, 2024, 15:1432851
|
|
| S2555 |
Clarithromycin
|
Clarithromycin (A-56268) is a macrolide antibiotic and a CYP3A4 inhibitor, used to treat a number of bacterial infections. |
- Circulation, 2024, 150(7):563-576
- Microorganisms, 2022, 10(7)1421
- Cell Biol Toxicol, 2021, 10.1007/s10565-021-09646-5
|
|
| S1635 |
Erythromycin
|
Erythromycin (E-Mycin) is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin (IC50=1.5 μg/ml). |
- Autophagy, 2025, 1-17.
- Infect Drug Resist, 2023, 16:4867-4879
- Infect Drug Resist, 2023, 16:4867-4879
|
|
| S2574 |
Tetracycline HCl
|
Tetracycline HCl (NCI-c55561) is a hydrochloride salt of tetracycline that is a broad-spectrum polyketide antibiotic. |
- Nat Commun, 2024, 15(1):2377
- Antiviral Res, 2020, 185:104993
- PLoS Pathog, 2020, 16;16(3):e1008341
|
|
| S1677 |
Chloramphenicol
|
Chloramphenicol (Chloromycetin) is a bacteriostatic by inhibiting protein synthesis. |
- Cell Rep, 2021, 34(3):108631
- EMBO Rep, 2021, e53081
- Oncotarget, 2018, 9(40):26086-26095
|
|
| S2510 |
Spectinomycin 2HCl
|
Spectinomycin 2HCl (Actinospectacin) is a new parenteral antibiotic prepared from Streptomyces spectabilis. |
- Cell Rep, 2020, 32(2):107897
|
|
| S2514 |
Tobramycin
|
Tobramycin (NSC 180514,Deoxykanamycin B, Nebramycin Factor 6) is an aminoglycoside antibiotic with an IC50 of 9.7 μM. |
- Oncotarget, 2018, 9(40):26086-26095
|
|
| S4490 |
Tetracycline
|
Tetracycline (TC) is a broad-spectrum antibiotic that exhibits activity against a wide range of microorganisms including gram-positive and gram-negative bacteria, chlamydiae, mycoplasmas, rickettsiae, and protozoan parasites. |
- Redox Biol, 2025, 84:103649
- bioRxiv, 2025, 2025.01.08.632009
- PeerJ, 2022, 10:e13719
|
|
| S3496 |
Lefamulin acetate (Xenleta)
|
Lefamulin acetate (Xenleta, BC-3781 acetate) is a pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP) treatment. It inhibits protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome, thus preventing the binding of transfer RNA for peptide transfer. |
- J Biol Chem, 2022, 298(5):101909
|
|
| S2315 |
Kanamycin sulfate
|
Kanamycin sulfate (Kanamycin monosulfate, Ophtalmokalixan) is an aminoglycoside antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections. |
- Heliyon, 2024, 10(11):e32571
- Oncotarget, 2018, 9(40):26086-26095
|
|
| E4867 |
Omadacycline
|
Omadacycline(Amadacycline) is an oral aminomethylcycline antibacterial antibiotic used to treat moderate-to-severe infections, such as community-acquired pneumonia and acute bacterial skin and skin structure infections caused by susceptible organisms. It inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. This compound has broad-spectrum antibacterial activity and is effective against Gram-positive and Gram-negative aerobic, anaerobic, and atypical bacteria. |
|
|